Skip to main content
Caplight Logo









Sons

Sons

Private
LondonHealthcare & Life Scienceshttps://sons.co.uk/

Last Round

VC Round

Dec 8, 2023

Total Funding Raised

$1.44M

Company Overview

Sons is a digital healthcare company that provides clinically backed hair loss and men's health treatment plans through an online subscription model.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Keywords

telehealthmen's healthdirect-to-consumerDTCsubscription pharmacyhair loss treatmenterectile dysfunction treatmentED treatmentremote consultationprescription deliverywellness supplementsdigital healthe-healthsubscription commerceonline pharmacy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sons Comparables

Compare Sons with similar companies based on industry and business-model similarity.

Sons comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Manual
87%
Numan
85%
ZipHealth Services Inc.
82%

Sons Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 8, 2023
SeedJan 1, 2020

Key People

Founding team and executive leadership

Adrian Gilbane

Co-Founder and COO

Founding Team

Sons Investors

Notable investors and investment history

Sons investors
InvestorRounds
BES Management DACVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 8, 2023

    $7.3M round led by BES Management DAC

Sons Filings

Explore SEC and related filing metadata, where available.

Sons filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sons's valuation, stock price, and market status.

Is Sons a public or private company?

Sons is a private company.

What is the current stock price of Sons?

Sons is a private company with no public stock price. No recent secondary market data is available.

How much is Sons worth (valuation)?

Valuation information for Sons is not publicly available.

Can I buy Sons stock?

Sons shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sons's last funding round?

Sons's most recent funding round was VC Round on December 8, 2023.

Who are the main investors in Sons?

Key investors in Sons include BES Management DAC.

Will Sons IPO soon?

No public IPO plans have been announced for Sons.

How can I track Sons secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sons's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range47
Year Founded2019
Last FundingDec 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?